Item 5. Other Information
ITEM 5. OTHER INFORMATION
See Note 8 to the Financial Statements for discussion of our prior period financial restatements.
19
Table of Contents
ITEM 6. EXHIBITS.
The following exhibits are filed or furnished as part of this quarterly report on Form 10-Q:
Exhibit No.
Description
31.1
*
Certification Pursuant to Section 302 of the Sarbanes-Oxley Act — Zackary S. Irani
31.2
*
Certification Pursuant to Section 302 of the Sarbanes-Oxley Act — Steve Sloan
32.1
*
Certification Pursuant to Section 906 of the Sarbanes-Oxley Act — Zackary S. Irani
32.2
*
Certification Pursuant to Section 906 of the Sarbanes-Oxley Act — Steve Sloan
101 Interactive data files pursuant to Rule 405 Regulation S-T, as follows:
101.INS-XBRL Instance Document
101.SCH-XBRL Taxonomy Extension Schema Document
101.CAL-XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF–XBRL Taxonomy Extension Definition Linkbase Document
101.LAB-XBRL Taxonomy Extension Label Linkbase Document
101.PRE-XBRL Taxonomy Extension Presentation Linkbase Document
*Filed herewith.
20
Table of Contents
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has fully caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
BIOMERICA, INC.
Date: January 12, 2022
By:
/S/ Zackary S. Irani
Zackary S. Irani
Chief Executive Officer
(Principal Executive Officer)
Date: January 12, 2022
By:
/S/ Steve Sloan
Steve Sloan
Chief Financial Officer
(Principal Financial Officer)
21
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.